Uncovering Cellular Diversity to Advance Clinical and Translational Research
Single cell sequencing is a next-generation sequencing method enabling in-depth characterization of biomolecules by uncovering genetic expression at single cell resolution. It has advantages over conventional bulk sequencing in its ability to detect rare cell types, uncover tumor heterogeneity, trace lineages, discover drug-resistant cell populations, and characterize complex cell populations such as immune cells in peripheral blood. Q2 utilizes leading technologies such as the 10x Genomics® Chromium™ and Illumina® NovaSeq™ platforms. We can meet your sequencing needs with our extensive services spanning the clinical research continuum combined with our global laboratory network and expert support team.